Literature DB >> 19506904

Role of reactive oxygen species in proapoptotic ability of oncogenic H-Ras to increase human bladder cancer cell susceptibility to histone deacetylase inhibitor for caspase induction.

Shambhunath Choudhary1, Hwa-Chain Robert Wang.   

Abstract

PURPOSE: Reveal mechanisms for the novel proapoptotic ability of oncogenic H-Ras to increase cell susceptibility to a histone deacetylase inhibitor (HDACI) FR901228 for inducing caspase activation and selective apoptosis.
METHODS: Human urinary bladder cancer J82 and oncogenic H-Ras-expressing J82 cells were used to reveal differential induction of intracellular reactive oxygen species (ROS), caspase activation, and apoptosis by HDACI FR901228. ROS levels and caspase-8, -9, and -3/7 activities were measured by flow cytometry and luminescence assays, respectively. Specific inhibitors were used to suppress caspases and ROS. Western blot analysis determined modulators of caspase pathways.
RESULTS: ROS, caspase activity, and cell death was differentially increased by FR901228 in oncogenic H-Ras-expressing J82 versus parental cells. Blocking ROS resulted in reduced FR901228-induced cell death and caspase activation. Suppression of caspase-8 resulted in reduced FR901228-activated caspase-9 and -3/7. Suppression of caspase-9 resulted in reduced FR901228-activated caspase-3/7. Although FR901228 induced an ROS-dependent increase of FasL, FasL failed to induce caspase activation and cell death.
CONCLUSION: Increased ROS played an important role in the activation of the extrinsic and intrinsic caspase pathways to cooperatively induce executioner caspase-3/7 through a novel FasL-independent pathway in FR901228-induced selective apoptosis of oncogenic H-Ras-expressing J82 versus parental cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506904     DOI: 10.1007/s00432-009-0608-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  52 in total

1.  Titrating the effects of mitochondrial complex I impairment in the cell physiology.

Authors:  A Barrientos; C T Moraes
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

2.  Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-alpha.

Authors:  R Liu; B Li; M Qiu
Journal:  Oncogene       Date:  2001-03-22       Impact factor: 9.867

Review 3.  Prospects: histone deacetylase inhibitors.

Authors:  Milos Dokmanovic; Paul A Marks
Journal:  J Cell Biochem       Date:  2005-10-01       Impact factor: 4.429

4.  Superoxide generation in v-Ha-ras-transduced human keratinocyte HaCaT cells.

Authors:  J Q Yang; S Li; F E Domann; G R Buettner; L W Oberley
Journal:  Mol Carcinog       Date:  1999-11       Impact factor: 4.784

5.  Substrate specificities of caspase family proteases.

Authors:  R V Talanian; C Quinlan; S Trautz; M C Hackett; J A Mankovich; D Banach; T Ghayur; K D Brady; W W Wong
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

6.  Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin.

Authors:  Jih I Chuang; Tsuey Y Chang; Hsiao S Liu
Journal:  Oncogene       Date:  2003-03-06       Impact factor: 9.867

Review 7.  FR-901228 Fujisawa/National Cancer Institute.

Authors:  David M Vigushin
Journal:  Curr Opin Investig Drugs       Date:  2002-09

Review 8.  ROS stress in cancer cells and therapeutic implications.

Authors:  Helene Pelicano; Dennis Carney; Peng Huang
Journal:  Drug Resist Updat       Date:  2004-04       Impact factor: 18.500

9.  Hypoxia/reoxygenation induces apoptosis through a ROS-mediated caspase-8/Bid/Bax pathway in human lymphocytes.

Authors:  Byeong Mo Kim; Hai Won Chung
Journal:  Biochem Biophys Res Commun       Date:  2007-09-18       Impact factor: 3.575

Review 10.  Histone deacetylases.

Authors:  Paul A Marks; Thomas Miller; Victoria M Richon
Journal:  Curr Opin Pharmacol       Date:  2003-08       Impact factor: 5.547

View more
  14 in total

Review 1.  Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC).

Authors:  Courtney Pollard; Steven C Smith; Dan Theodorescu
Journal:  Expert Rev Mol Med       Date:  2010-03-25       Impact factor: 5.600

2.  Differential induction of reactive oxygen species through Erk1/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells.

Authors:  Shambhunath Choudhary; Kusum Rathore; Hwa-Chain Robert Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-15       Impact factor: 4.553

3.  Differential effects of ethanol on bid, tBid, and Bax:tBid interactions in postnatal day 4 and postnatal day 7 rat cerebellum.

Authors:  Marieta B Heaton; Michael Paiva; Stacey Kubovec
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

Review 4.  Targeting Histone Deacetylases in Diseases: Where Are We?

Authors:  Rosaria Benedetti; Mariarosaria Conte; Lucia Altucci
Journal:  Antioxid Redox Signal       Date:  2014-03-06       Impact factor: 8.401

Review 5.  Oxidative stress in bladder cancer: an ally or an enemy?

Authors:  Fernando Mendes; Eurico Pereira; Diana Martins; Edgar Tavares-Silva; Ana Salomé Pires; Ana Margarida Abrantes; Arnaldo Figueiredo; Maria Filomena Botelho
Journal:  Mol Biol Rep       Date:  2021-03-17       Impact factor: 2.316

6.  Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors.

Authors:  Gonzalo Lopez; Keila Torres; Juehui Liu; Belinda Hernandez; Eric Young; Roman Belousov; Svetlana Bolshakov; Alexander J Lazar; John M Slopis; Ian E McCutcheon; David McConkey; Dina Lev
Journal:  Cancer Res       Date:  2010-11-16       Impact factor: 12.701

Review 7.  Reactive oxygen species-mediated therapeutic control of bladder cancer.

Authors:  Hwa-Chain R Wang; Shambhunath Choudhary
Journal:  Nat Rev Urol       Date:  2011-10-04       Impact factor: 14.432

8.  Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells.

Authors:  Benigno C Valdez; Jonathan E Brammer; Yang Li; David Murray; Esmeralda C Teo; Yan Liu; Chitra Hosing; Yago Nieto; Richard E Champlin; Borje S Andersson
Journal:  Leuk Res       Date:  2016-05-27       Impact factor: 3.156

9.  The Interplay between ROS and Ras GTPases: Physiological and Pathological Implications.

Authors:  Elisa Ferro; Luca Goitre; Saverio Francesco Retta; Lorenza Trabalzini
Journal:  J Signal Transduct       Date:  2011-11-30

10.  A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis.

Authors:  Pawat Pattarawat; Jessica T Hunt; Jacob Poloway; Collin J Archibald; Hwa-Chain Robert Wang
Journal:  Cancer Chemother Pharmacol       Date:  2021-05-27       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.